CN115779025B - Traditional Chinese medicine preparation for treating female acne and preparation method thereof - Google Patents
Traditional Chinese medicine preparation for treating female acne and preparation method thereof Download PDFInfo
- Publication number
- CN115779025B CN115779025B CN202211584193.0A CN202211584193A CN115779025B CN 115779025 B CN115779025 B CN 115779025B CN 202211584193 A CN202211584193 A CN 202211584193A CN 115779025 B CN115779025 B CN 115779025B
- Authority
- CN
- China
- Prior art keywords
- parts
- acne
- traditional chinese
- chinese medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 86
- 239000003814 drug Substances 0.000 title claims abstract description 85
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 80
- 238000002360 preparation method Methods 0.000 title claims abstract description 53
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 25
- 208000010201 Exanthema Diseases 0.000 claims abstract description 24
- 201000005884 exanthem Diseases 0.000 claims abstract description 24
- 206010037844 rash Diseases 0.000 claims abstract description 24
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 23
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 23
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 23
- 244000197580 Poria cocos Species 0.000 claims abstract description 23
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 23
- 235000020224 almond Nutrition 0.000 claims abstract description 23
- 241000132012 Atractylodes Species 0.000 claims abstract description 22
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 20
- 240000003582 Platycodon grandiflorus Species 0.000 claims abstract description 20
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 12
- 239000011248 coating agent Substances 0.000 claims abstract description 12
- 238000000576 coating method Methods 0.000 claims abstract description 12
- 240000001949 Taraxacum officinale Species 0.000 claims abstract 3
- 239000000843 powder Substances 0.000 claims description 33
- 244000236658 Paeonia lactiflora Species 0.000 claims description 21
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 21
- 244000061520 Angelica archangelica Species 0.000 claims description 20
- 241000576429 Forsythia suspensa Species 0.000 claims description 20
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 11
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 11
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 11
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 11
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 11
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 11
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 11
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 11
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 11
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 50
- 210000000952 spleen Anatomy 0.000 abstract description 47
- 239000008280 blood Substances 0.000 abstract description 38
- 210000004369 blood Anatomy 0.000 abstract description 35
- 230000007812 deficiency Effects 0.000 abstract description 21
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 19
- 208000026435 phlegm Diseases 0.000 abstract description 19
- 239000003053 toxin Substances 0.000 abstract description 19
- 231100000765 toxin Toxicity 0.000 abstract description 18
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 230000001815 facial effect Effects 0.000 abstract description 8
- 238000005728 strengthening Methods 0.000 abstract description 7
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 5
- 230000008506 pathogenesis Effects 0.000 abstract description 4
- 238000005520 cutting process Methods 0.000 abstract description 2
- 210000004373 mandible Anatomy 0.000 abstract description 2
- 241001108921 Asclepias asperula Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 238000001035 drying Methods 0.000 description 28
- 230000001737 promoting effect Effects 0.000 description 25
- 229940079593 drug Drugs 0.000 description 24
- 241000245665 Taraxacum Species 0.000 description 23
- 238000011282 treatment Methods 0.000 description 22
- 210000004072 lung Anatomy 0.000 description 21
- 208000002193 Pain Diseases 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 15
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 15
- 238000003745 diagnosis Methods 0.000 description 15
- 229940088597 hormone Drugs 0.000 description 15
- 239000005556 hormone Substances 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 14
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 13
- 235000013305 food Nutrition 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 13
- 206010033733 Papule Diseases 0.000 description 12
- 206010037888 Rash pustular Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 230000002757 inflammatory effect Effects 0.000 description 12
- 208000029561 pustule Diseases 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 208000011580 syndromic disease Diseases 0.000 description 12
- 241001092040 Crataegus Species 0.000 description 11
- 241000721047 Danaus plexippus Species 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 11
- 206010016807 Fluid retention Diseases 0.000 description 10
- 240000001972 Gardenia jasminoides Species 0.000 description 10
- 206010033557 Palpitations Diseases 0.000 description 10
- 235000008216 herbs Nutrition 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 9
- 238000009825 accumulation Methods 0.000 description 9
- 235000019658 bitter taste Nutrition 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 241000972673 Phellodendron amurense Species 0.000 description 8
- 208000033809 Suppuration Diseases 0.000 description 8
- 208000022531 anorexia Diseases 0.000 description 8
- 206010061428 decreased appetite Diseases 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 208000012641 Pigmentation disease Diseases 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 230000019612 pigmentation Effects 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 238000002203 pretreatment Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 210000001732 sebaceous gland Anatomy 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 244000018633 Prunus armeniaca Species 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 239000003098 androgen Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000002354 daily effect Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000003780 keratinization Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 235000019633 pungent taste Nutrition 0.000 description 5
- 230000037380 skin damage Effects 0.000 description 5
- 206010040882 skin lesion Diseases 0.000 description 5
- 231100000444 skin lesion Toxicity 0.000 description 5
- 244000111489 Gardenia augusta Species 0.000 description 4
- 235000018958 Gardenia augusta Nutrition 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 241001106477 Paeoniaceae Species 0.000 description 4
- 241000972672 Phellodendron Species 0.000 description 4
- 102000008078 Sterol Regulatory Element Binding Protein 1 Human genes 0.000 description 4
- 108010074436 Sterol Regulatory Element Binding Protein 1 Proteins 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 208000031513 cyst Diseases 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 231100000046 skin rash Toxicity 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 241000382455 Angelica sinensis Species 0.000 description 3
- 241000208173 Apiaceae Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 description 3
- 241000207929 Scutellaria Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 3
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000006651 lactation Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 231100000314 skin damage score Toxicity 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 2
- 241000657480 Crataegus pinnatifida Species 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 description 2
- 206010060710 Galactostasis Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241000244365 Ligusticum sinense Species 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241001522129 Pinellia Species 0.000 description 2
- 235000006751 Platycodon Nutrition 0.000 description 2
- 244000274050 Platycodon grandiflorum Species 0.000 description 2
- 240000004534 Scutellaria baicalensis Species 0.000 description 2
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 230000003325 follicular Effects 0.000 description 2
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 2
- 229960004675 fusidic acid Drugs 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000010271 massa medicata fermentata Substances 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 230000024121 nodulation Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229930189914 platycodon Natural products 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 241000748223 Alisma Species 0.000 description 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 235000010864 Armeniaca mandshurica Nutrition 0.000 description 1
- 244000147617 Armeniaca mandshurica Species 0.000 description 1
- 244000141006 Armeniaca sibirica Species 0.000 description 1
- 235000015577 Armeniaca sibirica Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 102000015735 Beta-catenin Human genes 0.000 description 1
- 108060000903 Beta-catenin Proteins 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 101100238302 Caenorhabditis elegans morc-1 gene Proteins 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000510667 Conioselinum Species 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 235000014493 Crataegus Nutrition 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000002245 Penicillium camembertii Nutrition 0.000 description 1
- 241001079007 Phellodendron chinense Species 0.000 description 1
- 241001522232 Pinellia ternata Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 241000292546 Taraxacum mongolicum Species 0.000 description 1
- 241000331598 Trombiculidae Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 102000001307 androgen receptors Human genes 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940093611 fu ling Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000004378 sebocyte Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 235000019590 thick flavour Nutrition 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine preparation for treating female acne and a preparation method thereof, wherein the medicine is prepared from dandelion, fructus forsythiae, bighead atractylodes rhizome, chinese angelica, poria cocos, ligusticum wallichii, white paeony root, rhizoma alismatis, radix angelicae, almond and balloonflower root by adding, subtracting, modifying and cutting: radix Scutellariae for patients with rash and cheek diseases; fructus Gardeniae and cortex Phellodendri can be added for patients with rash and chin and mandible; facial greasiness: adding the three immortals; rhizoma Pinelliae with thick and greasy coating. The invention has the effects of clearing heat and detoxicating, strengthening spleen and resolving fluid retention and harmonizing qi and blood for the female acne with heat toxin accumulated in the upper-jiao head, face, chest and back, and the basis of pathogenesis of phlegm and fluid retention and resolving heat, namely spleen deficiency fluid retention or qi and blood disharmony. All Fang Hanwen are used together to achieve the purpose of eliminating acne.
Description
Technical Field
The invention relates to the field of medicines, in particular to a traditional Chinese medicine preparation for treating female acne and a preparation method thereof.
Background
Acne Vulgaris (abbreviated as "Acne", acne Vulgaris, AV) is a chronic inflammatory skin disease affecting the hair follicle-sebaceous glands, one of the common damage-tolerant skin diseases, and many patients, especially women, are saturated and disturbed by it. The pathogenesis of the acne is generally considered to be related to hormone level imbalance, propionibacterium acnes colonization, hair follicle keratinization abnormality, genetic related factors and the like, wherein the hormone level has important influence on the occurrence and development of the disease, the hormone level is mainly used for stimulating the excessive secretion of sebaceous glands by promoting the excessive keratinization of the hair follicle, and the specific mechanism is as follows: 1) Fibroblast production is promoted by affecting fibroblasts, which leads to excessive keratinization of the follicular orifice, sebum accumulation, and inflammatory production. 2) By promoting the occurrence of the mammalian rapamycin target C1 pathway (mORC 1), the sterol regulatory element binding protein-1 (SREBP-1) is activated to promote the synthesis and secretion of lipids.
In clinical practice, the inventor finds that in addition to the heat toxin syndrome, female acne patients commonly have symptoms of deficiency-excess inclusion and cold-heat mix-up, such as: cold limbs, pale complexion or pale complexion, tender flesh, calm and lazy movements, shortness of breath and lazy speaking, tiredness and hypodynamia or dizziness and palpitation, insomnia and dreaminess, pale and fat tongue with white or thick greasy coating, deep and thin and weak pulse and the like, which are often accompanied with thirst and poor appetite, red face, greasy and desquamation, yellow greasy coating and yellow greasy coating, and rash is manifested as red pimple, painful nodule and cyst, and the rash is obviously aggravated after eating and staying up night. However, the existing medicines and treatment methods for treating the diseases are more, but the treatment effect is not ideal, the disease is easy to relapse, and radical cure is difficult to achieve.
Disclosure of Invention
The invention aims at a traditional Chinese medicine compound for treating female acne and a preparation method thereof, and has obvious curative effects on female heat toxin flaming up and skin accumulation (heat toxin upper accumulation or heat toxin skin accumulation) accompanied with spleen deficiency and fluid retention or qi and blood disharmony type acne.
The technical scheme of the invention is as follows:
a traditional Chinese medicine preparation for treating female acne comprises the following medicinal active ingredients in parts by weight: is prepared from dandelion 100-220 parts, weeping forsythia 100-220 parts, bighead atractylodes rhizome 80-200 parts, chinese angelica 40-160 parts, poria cocos 80-200 parts, ligusticum wallichii 40-160 parts, white peony root 100-450 parts, alisma 100-220 parts, dahurian angelica root 50-180 parts, apricot kernel 50-180 parts and balloonflower root 50-180 parts.
The traditional Chinese medicine preparation for treating female acne comprises the following medicinal active ingredients in parts by weight: is prepared from 130-170 parts of dandelion, 130-170 parts of weeping forsythia, 100-140 parts of bighead atractylodes rhizome, 70-110 parts of angelica, 100-140 parts of poria cocos, 70-110 parts of ligusticum wallichii, 200-400 parts of white peony root, 130-170 parts of rhizoma alismatis, 80-120 parts of radix angelicae, 80-120 parts of almond and 80-120 parts of balloonflower root.
Specifically, the traditional Chinese medicine preparation for treating female acne comprises the following medicinal active ingredients in parts by weight: is prepared from 150 parts of dandelion, 150 parts of weeping forsythia, 120 parts of bighead atractylodes rhizome, 90 parts of Chinese angelica, 120 parts of poria cocos, 90 parts of ligusticum wallichii, 300 parts of white peony root, 150 parts of rhizoma alismatis, 100 parts of radix angelicae, 100 parts of almond and 100 parts of platycodon grandiflorum.
More specifically, the traditional Chinese medicine preparation for treating female acne has the defect that acne patients have rash with cheeks, and 100-220 parts of radix scutellariae is added in the formula.
More specifically, the traditional Chinese medicine preparation for treating female acne is mainly prepared from 50-200 parts of cape jasmine and 40-160 parts of salted phellodendron bark in the formula, wherein the acne patient has rash and chin and lower jaw.
More specifically, the traditional Chinese medicine preparation for treating female acne has thick greasy coating on acne patients, and 40-160 parts of rhizoma pinellinae praeparata are added in the formula.
More specifically, the traditional Chinese medicine preparation for treating female acne has oily face for acne patients, and 40-160 parts of malt, 40-160 parts of hawthorn and 40-160 parts of Jianqu are added in the formula.
The preparation method of the traditional Chinese medicine preparation for treating female acne comprises the steps of weighing all the medicinal materials according to a proportion, processing according to a conventional preparation method, combining with pharmaceutically acceptable auxiliary materials and matrixes in the medicines, and preparing corresponding oral preparations.
The oral preparation comprises powder, capsule, tablet, pill, granule or soft extract.
The preparation method of the powder comprises the following steps: weighing the raw materials according to a certain proportion, pulverizing into fine powder, and mixing uniformly.
The preparation method of the capsule comprises the following steps: weighing the medicinal materials according to the prescription proportion, adding 6-10 times of water to soak for 0.5-2h, decocting for 2-3 times each time for 1-2h, merging the decoctions, uniformly mixing, concentrating to 80% of the original medicinal liquid, filtering while the hot, concentrating the filtrate to an extract with relative density of 1.15-1.25 at 70 ℃, drying at 70 ℃ to obtain dry extract, pulverizing into fine powder, adding starch slurry with the preparation amount of 10%, granulating, drying, finishing granules, and filling capsules to obtain the traditional Chinese medicine.
The preparation method of the tablet comprises the following steps: weighing the medicinal materials according to the prescription proportion, adding 6-10 times of water to soak for 0.5-2h, decocting for 2-3 times, each time for 1-2h, mixing decoctions, concentrating into 80% of the original medicinal liquid,
filtering while hot, concentrating the filtrate to extract with relative density of 1.20-1.30 at 70deg.C, drying at 70deg.C, pulverizing into fine powder to obtain dry extract, adding 10% dextrin, granulating with 70% ethanol as wetting agent, drying, tabletting, and film coating to obtain tablet.
The preparation method of the granule comprises the following steps: weighing the medicinal materials according to the prescription proportion, soaking for 0.5-2h by adding 6-10 times of water, decocting for 2-3 h each time, mixing decoctions, concentrating into 80% of the original medicinal liquid, filtering while hot, concentrating the filtrate into extract with relative density of 1.20-1.30 at 70 ℃, drying the extract at 70 ℃, pulverizing into fine powder to obtain dry extract, taking 10% sucrose, granulating with 80% ethanol as wetting agent, drying at 60 ℃ after granulating, sieving with 12 mesh sieve for 1 time, and sieving with 60 mesh sieve to obtain the granule.
The preparation method of the granule comprises the following steps: weighing the medicinal materials according to the prescription proportion, adding 6-10 times of water to soak for 0.5-2h, decocting for 2-3 times, each time for 0.5-2h, merging the decoctions, mixing uniformly, concentrating into 80% of the original medicinal liquid, filtering while the medicinal liquid is hot, concentrating the filtrate into extract with relative density of 1.20-1.30 at 70 ℃, adding honey, and stirring uniformly to obtain the soft extract.
Compared with the prior art, the invention has the following beneficial effects:
the traditional Chinese medicine compound for treating acne and the preparation method thereof are prepared from dandelion, fructus forsythiae, bighead atractylodes rhizome, chinese angelica, poria cocos, ligusticum wallichii, radix paeoniae alba, rhizoma alismatis, radix angelicae, almond and platycodon grandiflorum. Radix Scutellariae, fructus Gardeniae, cortex Phellodendri, radix Clematidis (fructus Hordei Germinatus, fructus crataegi, massa Medicata Fermentata), and rhizoma Pinelliae Preparata can also be added; the properties and efficacy of each component are as follows: the herba Taraxaci is dried whole plant of Compositae plant Pu Ying Taraxacum mongolicum hand-Mazz, herba Taraxaci Taraxacum borealisinense Kitam or congeneric plant; digging and removing flowers from spring to autumn when they are initially opened; impurity, cleaning and bitter drying; sweet in taste and cold in nature; enter liver and stomach meridians; has effects of clearing heat and detoxicating, detumescence and resolving hard mass, inducing diuresis and treating stranguria; can be used for treating furuncle, acute mastitis, scrofula, conjunctival congestion, pharyngalgia, pulmonary abscess, acute appendicitis, jaundice due to damp-heat, and stranguria due to heat. Fructus forsythiae is a dried fruit of Forsythia suspensa Forsythia suspensa (thunder.) Vahl belonging to Oleaceae; bitter taste and slightly cold nature; enter the lung, heart and small intestine meridians; has effects of clearing heat and detoxicating, detumescence and resolving hard mass, dispelling wind and heat; can be used for treating carbuncle, scrofula, acute mastitis, erysipelas, wind-heat type common cold, epidemic febrile disease, excessive heat, polydipsia, coma, speckle, and stranguria due to heat. The Atractylodis rhizoma is dry rhizome of Atractylodes macrocephala Atractylodes macrocephala Koidz; digging when the lower part She Kuhuang and the upper part leaves become brittle in winter, removing sediment, drying or sun-drying, and removing fibrous roots; bitter and sweet in taste and warm in nature; spleen and stomach meridian; has the effects of tonifying qi of spleen, eliminating dampness, promoting diuresis, stopping sweat and preventing miscarriage; can be used for treating spleen deficiency, anorexia, abdominal distention, diarrhea, phlegm retention, dizziness, palpitation, edema, spontaneous perspiration, and fetal movement. Angelica sinensis is the dry root of Angelica sinensis Angelica sinensis (Oliv.) Diels of Umbelliferae; digging in the late autumn, removing fibrous roots and silt, bundling into small bundles after water is slightly evaporated, and slowly smoking with smoke; sweet and pungent taste and warm nature; enter liver, heart and spleen meridians; has effects of replenishing blood, promoting blood circulation, regulating menstruation, relieving pain, loosening bowel, and relieving constipation; can be used for treating sallow complexion due to blood deficiency, dizziness, palpitation, menoxenia, amenorrhea, dysmenorrhea, abdominal pain due to deficiency-cold, rheumatalgia, traumatic injury, carbuncle, skin ulcer, and constipation due to intestinal dryness; the wine angelica has the effects of promoting blood circulation and dredging channels; can be used for treating amenorrhea, dysmenorrhea, rheumatalgia, traumatic injury. Poria is dry sclerotium of Polyporaceae fungus Poria cocos (Schw.) Wolf; sweet and light in taste and neutral in nature; return to heart, lung, spleen and kidney meridians; has effects in promoting diuresis, eliminating dampness, invigorating spleen, and calming heart; can be used for treating edema, oliguria, phlegm retention, palpitation, spleen deficiency, anorexia, loose stool, diarrhea, uneasiness, palpitation, and insomnia. Rhizoma Ligustici Chuanxiong is dried rhizome of Ligusticum chuanxiong Hort Ligusticum chuanxiong Hort of Umbelliferae; digging in summer when the node discs on the stems are obviously protruded and are slightly purple, removing sediment, drying after sun drying, and removing fibrous roots; pungent taste and warm nature; meridian tropism between liver, gallbladder and pericardium; has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind, and relieving pain; can be used for treating chest pain, hypochondrium pain, traumatic injury, menoxenia, amenorrhea, dysmenorrhea, abdominal pain, headache, and rheumatalgia. Radix Paeoniae alba is dry root of Pall Paeonia lactiflora of Pall of Ranunculaceae; bitter and sour in taste and slightly cold in nature; enter liver and spleen meridians; has effects of nourishing blood, regulating menstruation, astringing yin, suppressing sweating, softening liver, relieving pain, and suppressing liver yang; can be used for treating sallow complexion due to blood deficiency, menoxenia, spontaneous perspiration, night sweat, hypochondriac pain, abdominal pain, limb contracture pain, headache and dizziness. The Alismatis rhizoma is dry tuber of Alisma orientale (Sam.) Juzep; digging when stem leaves begin to wither in winter, cleaning, drying, and removing fibrous roots and crude skin; sweet and light in taste and cold in nature. Kidney and bladder meridian; has effects of promoting diuresis, removing dampness, clearing heat, eliminating turbid pathogen, and reducing blood lipid; can be used for treating dysuria, edema, distention, diarrhea, oliguria, dizziness due to phlegm and fluid, stranguria due to heat, and hyperlipidemia. Radix Angelicae Dahuricae is dry root of radix Angelicae Dahuricae Angelica dahurica (Fisch. Ex Hoffm.) or radix Angelicae Dahuricae Angelica dahurica (Fisch. Ex Hoffm.) of Umbelliferae; collecting in summer and autumn She Huangshi, removing fibrous root and silt, and sun drying or low temperature drying; pungent taste and warm nature; the stomach, large intestine and lung channels; has effects of relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, relieving pain, dredging nasal orifices, eliminating dampness, stopping leukorrhagia, and relieving swelling and pus; can be used for treating common cold, headache, furuncle, bone pain, nasal obstruction, nasal discharge, allergic rhinitis, nasosinusitis, toothache, leukorrhagia, and pyocutaneous disease. The almond is a dried mature seed of mountain apricot Prunus armeniaca l.var. Ansu maxim, siberia apricot Prunus sibirica l, northeast apricot Prunus mandshurica (maxim.) Koehne or apricot Prunus armeniaca l; harvesting ripe fruits in summer, removing pulp and core shells, taking out seeds, and sun-drying; bitter taste and slightly warm nature; the Chinese medicinal composition has small toxicity; lung and large intestine channels; has effects of lowering qi, relieving cough and asthma, loosening bowel to relieve constipation; can be used for treating cough, asthma, chest fullness, excessive phlegm, constipation due to intestinal dryness. Radix Platycodi is dry root of radix Platycodi Platycodon grandiflorum (Jacq.) A.DC; bitter and pungent taste and neutral nature; enter lung meridian; has effects in dispersing lung qi, relieving sore throat, eliminating phlegm, and expelling pus; can be used for treating cough with excessive phlegm, chest distress, pharyngalgia, hoarseness, pulmonary abscess, and pus discharge. The Scutellariae radix is dry root of Scutellariae radix Scutellaria baicalensis Georgi of Labiatae; digging in spring and autumn, removing fibrous root and silt, sun drying, removing coarse skin, and sun drying; bitter taste and cold nature; the lung channel, the gallbladder channel, the spleen channel, the large intestine channel and the small intestine channel; has effects of clearing heat, eliminating dampness, purging pathogenic fire, removing toxic substances, stopping bleeding, and preventing miscarriage; can be used for treating damp-heat, summer-heat, chest distress, emesis, damp-heat distention and fullness, dysentery, jaundice, cough due to lung heat, polydipsia due to high fever, hematemesis, epistaxis, carbuncle, swelling, sore, and fetal movement. The fried gardenia is fried gardenia by a clear frying method; fructus Gardeniae is dried mature fruit of fructus Gardeniae Gardenia jasminoides Ellis of Rubiaceae plant; harvesting when the fruits are ripe and red-yellow for 9-11 months, removing the fruit stalks and impurities, steaming to the upper air or putting the fruits into boiling water for scalding slightly, taking out and drying; bitter in flavor and cold in nature. Return to heart, lung and triple energizer meridians; has effects in purging pathogenic fire, relieving restlessness, clearing away heat and dampness, cooling blood, and removing toxic substances; the external use has the effects of detumescence and pain relief; can be used for treating febrile vexation, jaundice due to damp-heat, stranguria, hematemesis, conjunctival congestion, swelling and pain, and pyocutaneous disease due to pathogenic fire; it is indicated for sprain, contusion and pain. Cortex Phellodendri is dried bark of cortex Phellodendri Phellodendron chinense Schneid of Rutaceae; bitter taste and cold nature; kidney and bladder meridian; has effects of clearing heat, eliminating dampness, purging pathogenic fire, removing steam, removing toxic substances, and treating sore; can be used for treating damp-heat diarrhea, jaundice, dark urine, itching and leukorrhagia, heat stranguria, tinea pedis , bone steaming and fatigue heat, night sweat, spermatorrhea, pyocutaneous disease, swelling and toxin, and eczema. Salted phellodendron bark, cortex Phellodendri, radix Phellodendri, has the effect of nourishing yin to reduce pathogenic fire. Is used for treating night sweat and bone steaming due to yin deficiency and fire excess. Malt is processed product of mature fruit of Hordeum vulgare L of Gramineae by germination and drying; sweet in taste and neutral in nature; spleen and stomach meridian; has effects in promoting qi circulation, resolving food stagnation, invigorating spleen, stimulating appetite, and promoting lactation; can be used for treating dyspepsia, abdominal distention and pain, spleen deficiency, galactostasis, breast pain, female weaning, liver Yu Xie pain, and liver and stomach qi pain; the raw malt has the effects of strengthening spleen and stomach, soothing liver and promoting qi circulation; the fried malt has the effects of promoting qi circulation, promoting digestion and promoting lactation for treating spleen deficiency and anorexia and galactostasis; can be used for treating dyspepsia, and female with weaning; the burnt malt has the effects of promoting digestion and resolving food stagnation; can be used for treating food retention, abdominal distention and pain. Fructus crataegi is processed product of dried mature fruit of fructus crataegi Crataegus pinnatifida Bge or fructus crataegi Crataegus pinnatifida Bge. Var. Major N.E.Br. Of Rosaceae; harvesting in autumn, slicing, drying, parching with clear parching method (general rule 0213) to brown on the surface and yellow brown inside to obtain fructus crataegi; sour and sweet taste, slightly warm nature; spleen, stomach and liver meridian; has effects of resolving food stagnation, invigorating stomach, activating qi-flowing, removing blood stasis, eliminating turbid pathogen, and reducing blood lipid; can be used for treating food stagnation, gastric distention, diarrhea, abdominal pain, blood stasis amenorrhea, puerperal blood stasis, thoracoabdominal pain, chest pain, hernia pain, and hyperlipidemia; the food-digesting and stagnation-removing effects of the scorched hawthorns are enhanced; it can be used for treating food stagnation, diarrhea, and dysentery. The Massa Medicata Fermentata is a yellow brown rectangular block with rough outer surface, yellow brown color, white mold, loose section, yellow brown smell and slight taste; has effects in relieving exterior syndrome; can be used for treating headache due to cold and heat, food stagnation, emesis and fullness. Rhizoma Pinelliae Preparata is processed product of rhizoma Pinelliae; pinellia ternate is a dried tuber of the plant Pinellia ternate Pinellia ternata (thunder.) of the family arisaemaceae; pungent taste and warm nature; spleen, stomach and lung meridian; has effects of eliminating dampness and phlegm; can be used for treating cough and asthma with excessive phlegm, phlegm retention, palpitation, dizziness, and headache.
And (3) square solution:
monarch drug: dandelion and fructus forsythiae; radix Scutellariae.
Fructus forsythiae, which enters lung, heart and gallbladder meridians, has the effects of clearing heat and detoxicating, resolving carbuncles and resolving masses, dispelling wind and dissipating heat, and is good at treating carbuncles and furuncles caused by heat toxin and fire toxin, and is called as "sores and holy medicines"; dandelion is bitter and cold, enters liver and stomach meridians, can clear heat of liver and stomach, can reduce swelling and dissipate nodulation, and can take the theory of treating upper Jiao Ruyu, not light and not easy, and the dandelion is light in texture, moves away upper jiao and is good at clearing heat toxin of muscle and skin striae. For the compatibility with Lian Qiao, it is used to clear up Jiao Lire excessive fire, dissipate nodulation and reduce swelling; baical skullcap root, radix Scutellariae, bitter in flavor, cold in nature, dry in dampness and clear lung heat, is the principal drug for treating acne of wind-heat type in lung channel. The dandelion and the weeping forsythiae capsule are combined as monarch drugs, or combined with the baikal skullcap root as monarch drugs, and the functions of clearing heat, detoxicating and resolving masses, or clearing lung heat, detoxicating and resolving masses are achieved together.
Ministerial drugs: bighead atractylodes rhizome, poria cocos and rhizoma alismatis; angelica, ligusticum wallichii and white paeony root; gardenia jasminoides ellis and phellodendron amurense.
(1) Atractylodis rhizoma, poria, alismatis rhizoma: bai Zhu and Fu Ling are combined, bai Zhu is bitter and sweet in taste and warm in nature, enters spleen and stomach meridians, and can tonify qi to restore spleen and transport, and dry dampness and promote diuresis to remove dampness and eliminate pathogenic factors, so that Bai Zhu is an essential herb for treating spleen deficiency syndrome and also an excellent herb for treating phlegm-fluid retention and edema. Poria is sweet and light and flat, sweet and can tonify, light and can permeate, strengthen body resistance, eliminate pathogenic factors, benefit heart and spleen, promote diuresis and remove dampness, and nourish but not drastic, benefit but not violent, and is an essential herb for strengthening spleen and excreting dampness, and also calm heart and tranquilize mind. Bai Zhu is mainly indicated for spleen strengthening and dampness eliminating, fu Ling is mainly for diuresis and dampness excreting, and two herbs are used together for one healthy and one excreting, so spleen can be healthy, dampness can be removed, swelling can be eliminated, fluid can be removed and all chiggers can be known to be removed. Alismatis rhizoma has sweet and bland taste, and cold property, and has effects of promoting diuresis, removing dampness, clearing heat and detumescence; cold energy removes heat, sweet and bland, excretes dampness, enters kidney and bladder meridians, so it is a good herb for purging fire of kidney and excreting dampness of bladder meridians, and is used to remove urine and damp and dispel heat; with Bai Zhu and Fu Ling, it is combined with Bai Zhu and Fu Ling, and has the actions of strengthening spleen qi, transporting dampness, promoting diuresis and resolving spleen stagnation, causing turbid yin to leak down, and reinforcing and reducing yang to supplement each other, strengthening spleen and removing dampness, and has very good efficacy. The three medicines are combined to treat damp and heat sources caused by spleen deficiency and phlegm retention internal stop, and the monarch drug is used as a first group of ministerial drugs.
(2) Angelica sinensis, ligusticum wallichii and radix paeoniae alba: dang Gui is pungent and sweet in nature and warm in nature, enters liver, heart and spleen meridians, is sweet and tonic and warm in nature, and has the effects of regulating qi and activating blood by replenishing blood, and is known as a holy medicine in blood; it is combined with Bai Zhu to nourish liver blood, regulate qi and blood, tonify spleen qi, promote spleen yang, supplement hardness and softness without stagnation, and is a common herb pair for regulating qi and blood. White peony root has sour and bitter taste, is slightly cold in nature, enters liver and spleen channels, and has the effects of nourishing blood, astringing yin, harmonizing nutrient and softening liver; when being combined with angelica, the angelica is used for replenishing blood to warm yang, the nature of the angelica is moving and mainly walking, the white paeony root is used for replenishing blood to nourish yin, the nature of the white paeony root is static and mainly guarding, and the two drugs are used for cold and warm simultaneously, and the functions of nourishing yin and replenishing blood, regulating liver and spleen, and activating blood and dissolving stasis are combined together, so that the Chinese angelica is mainly used for treating all diseases of deficiency of qi and blood and incoordination between liver and spleen; chuan Xiong is pungent and warm in nature, has the effects of promoting qi circulation, resolving depression, dispelling wind, removing dampness, promoting blood circulation and relieving pain, and can take into account qi and blood stasis, and is an essential herb for both qi and blood. The Chinese angelica and the white peony root are used for replenishing yin by blood herbs, and the hemlock parsley has the effect of promoting blood circulation and removing blood stasis by combining the three herbs. The three auxiliary monarch drugs have the functions of regulating and regulating qi and blood, detoxifying and resolving masses, so the three auxiliary monarch drugs are combined into a second group of ministerial drugs.
(3) Gardenia jasminoides ellis and phellodendron amurense: all are bitter and cold and dry dampness, but acne heat toxin is from triple energizer and phlegm-fluid retention blocks and hinders triple energizer qi transformation, so Zhi Zi can clear heat and dampness of triple energizer and qi movement is smooth, so that monarch drug can clear heat and detoxify. Huang Baiqing with the actions of nourishing yin and clearing heat. In addition, after the gardenia is stir-baked with salt, the phellodendron bark is prevented from being too cold and cool, and the cold is prevented from suppressing heat evil, and the herbs can enter the kidney (lower-jiao) to control fire of lower-jiao. The compatibility of the two herbs can clear the heat of lower energizer and triple energizer to assist the monarch drug, and the combination of the two herbs is the ministerial drug of the third group.
Adjuvant drug: radix Angelicae Dahuricae, semen Armeniacae amarum, and radix Platycodi; hawthorn, malt and Jian qu
Because phlegm-fluid retention is caused by spleen and stomach failing to transport and transform, it also depends on lung failing to disperse and descend, it can block striae and skin and hair, and almond taste is bitter and slightly warm, enters lung and large intestine meridians, and has the action of dispersing lung qi. Ji Geng is bitter and pungent, and pungent in flavor, dispersing lung qi, bitter in flavor, descending qi, ascending and descending, dispersing lung qi, benefiting chest and diaphragm, descending lung qi, eliminating phlegm and expelling pus, and moist in nature, can moisten intestines and relieve constipation. The two herbs are combined, one for lowering one for dispersing lung qi, relieving sore throat and resolving phlegm, and dredging intestines and stomach, and the three herbs are combined for promoting urination and defecation, so that heat toxin and phlegm dampness have the effect of removing pathogenic factors and guiding the pathogenic factors out. Radix angelicae is pungent and warm, can assist the monarch and minister with fragrance to eliminate dampness and dredge blood vessels, and also assist and treat the monarch and minister with the medicine bitter and diarrhea with impairment. Hawthorn fruit, malt and Jianqu can relieve food stagnation of flour food, cereal food and meat food, promote digestion, prevent phlegm-dampness from endogenous sources, and achieve the effects of removing fat and controlling oil. The warm nature of the herbs in this section can be used to monitor the bitter and cold nature of monarch and ministerial drugs, so as to prevent bitter and cold from hurting the healthy energy. So almond, platycodon root, malt and Jian qu are combined as adjuvant drugs.
The preparation method comprises the following steps: radix Platycodi and radix Angelicae Dahuricae are both combined with the guiding herbs because they are guided to the upper Jiao Toumian part and then go upward to the affected part.
In summary, the invention has the effects of clearing heat and resolving drink, strengthening spleen and replenishing qi and harmonizing qi and blood on the basis of pathogenesis of phlegm-fluid and resolving heat, namely spleen deficiency and drink stop, qi and blood disharmony, for female acne with heat toxin accumulated in upper-jiao heads, faces, chest and back. All Fang Hanwen are combined to achieve the purpose of eliminating acne.
Description of the drawings:
fig. 1: the effective rate of treatment;
fig. 2: case 1 pre-treatment picture;
fig. 3: case 1 post-treatment pictures;
fig. 4: case 3 pre-treatment picture;
fig. 5: case 3 post-treatment pictures.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to be limiting.
Example 1:
prescription: 15g of dandelion, 15g of weeping forsythia, 12g of bighead atractylodes rhizome, 9g of angelica, 12g of poria cocos, 9g of ligusticum wallichii, 30g of white peony root, 15g of rhizoma alismatis, 10g of radix angelicae, 10g of almond and 10g of platycodon grandiflorum;
the preparation process comprises the following steps: the preparation method comprises the steps of weighing the traditional Chinese medicines according to a proportion, crushing the traditional Chinese medicines into fine powder, and uniformly mixing the fine powder to obtain the powder.
The usage amount is as follows: one dose is taken every day, 5 days a week, 300ml of boiled water is brewed, 150ml of the filtered solution is taken every morning and evening, and the four weeks are continuous.
Example 2:
prescription: 10g of dandelion, 10g of weeping forsythia, 8g of bighead atractylodes rhizome, 4g of angelica, 8g of poria cocos, 4g of ligusticum wallichii, 10g of white peony root, 10g of rhizoma alismatis, 5g of radix angelicae, 5g of almond, 5g of platycodon grandiflorum and 10g of radix scutellariae;
the preparation process comprises the following steps: weighing the medicinal materials according to the prescription proportion, soaking the medicinal materials in 6 times of water for 0.5h, decocting for 3 times, each time for 2h, combining the three decoctions, uniformly mixing, concentrating to 80% of the original medicinal liquid, filtering while the hot, concentrating the filtrate to extract with relative density of 1.15-1.25 at 70 ℃, drying at 70 ℃ to obtain dry extract, pulverizing into fine powder, adding starch slurry with the preparation amount of 10%, granulating, drying, finishing, and filling into capsules to obtain the capsule.
The usage amount is as follows: 3 times daily, 2-4g once, and is continuously taken for four weeks.
Example 3:
22g of dandelion, 22g of weeping forsythia, 20g of bighead atractylodes rhizome, 16g of angelica, 20g of poria cocos, 16g of ligusticum wallichii, 45g of white peony root, 22g of rhizoma alismatis, 18g of radix angelicae, 18g of almond, 18g of platycodon grandiflorum, 20g of gardenia and 16g of salted phellodendron;
the preparation process comprises the following steps: weighing the medicinal materials according to the prescription proportion, soaking the medicinal materials in 8 times of water for 0.5h, decocting for 2 times, each time for 1h, combining the two decoctions, mixing uniformly, concentrating to 80% of the original medicinal liquid, filtering while the hot, concentrating the filtrate to extract with relative density of 1.20-1.30 at 70 ℃, drying the extract at 70 ℃, pulverizing into fine powder to obtain dry extract, adding 10% dextrin, granulating with 70% ethanol as wetting agent, drying, tabletting, and film coating to obtain the tablet.
The usage amount is as follows: 3 times daily, 2-4g once, and is continuously taken for four weeks.
Example 4:
15g of dandelion, 18g of weeping forsythia, 10g of bighead atractylodes rhizome, 9g of angelica, 12g of poria cocos, 14g of ligusticum wallichii, 25g of white peony root, 10g of rhizoma alismatis, 11g of radix angelicae, 15g of almond, 5g of platycodon grandiflorum, 9g of malt, 12g of hawthorn and 8g of Jian qu;
the preparation process comprises the following steps: weighing the medicinal materials according to the prescription proportion, soaking the medicinal materials in 10 times of water for 0.5h, decocting for 3 times, 1.5h each time, merging the three decoctions, uniformly mixing, concentrating to 80% of the original medicinal liquid, filtering while the hot, concentrating the filtrate to an extract with relative density of 1.20-1.30 at 70 ℃, drying the extract at 70 ℃, pulverizing into fine powder to obtain dry extract, granulating 20% of sucrose with 80% ethanol as a wetting agent, granulating, drying at 60 ℃, sieving with a 12-mesh sieve for 1 time, and sieving with a 60-mesh sieve to obtain fine powder, thus obtaining the granule.
The usage amount is as follows: is administered 3 times daily, 4-6g once, and continuously for four weeks.
Example 5:
20g of dandelion, 20g of weeping forsythia, 16g of bighead atractylodes rhizome, 4g of Chinese angelica, 11g of poria cocos, 5g of ligusticum wallichii, 25g of white peony root, 12g of rhizoma alismatis, 5g of radix angelicae, 10g of almond, 15g of platycodon grandiflorum and 9g of rhizoma pinellinae praeparata;
the preparation process comprises the following steps: the preparation method comprises the steps of weighing the traditional Chinese medicines according to a proportion, crushing the traditional Chinese medicines into fine powder, and uniformly mixing the fine powder to obtain the powder.
The usage amount is as follows: one dose is taken every day, 5 days a week, 300ml of the medicine is brewed with boiled water, 150ml of the medicine is taken every morning and evening, and the medicine is continuously taken for four weeks.
Example 6:
10g of dandelion, 10g of weeping forsythia, 12g of bighead atractylodes rhizome, 14g of angelica, 16g of poria cocos, 5g of ligusticum wallichii, 20g of white peony root, 15g of rhizoma alismatis, 15g of radix angelicae, 6g of almond, 8g of platycodon grandiflorum, 15g of radix scutellariae, 12g of gardenia and 8g of salted phellodendron;
the preparation process comprises the following steps: weighing the medicinal materials according to the prescription proportion, soaking the medicinal materials in 6 times of water for 0.5h, decocting for 3 times, each time for 2h, combining the three decoctions, uniformly mixing, concentrating to 80% of the original medicinal liquid, filtering while the hot, concentrating the filtrate to extract with relative density of 1.15-1.25 at 70 ℃, drying at 70 ℃ to obtain dry extract, pulverizing into fine powder, adding starch slurry with the preparation amount of 10%, granulating, drying, finishing, and filling into capsules to obtain the capsule.
The usage amount is as follows: 3 times daily, 2-4g once, and is continuously taken for four weeks.
Example 7:
prescription: 15g of dandelion, 15g of weeping forsythia, 12g of bighead atractylodes rhizome, 9g of angelica, 12g of poria cocos, 9g of ligusticum wallichii, 30g of white paeony root, 15g of rhizoma alismatis, 10g of radix angelicae, 10g of almond, 10g of platycodon grandiflorum, 15g of radix scutellariae, 10g of gardenia, 9g of salted phellodendron, 9g of malt, 9g of hawthorn, 9g of starter propagation and 9g of rhizoma pinellinae praeparata;
the preparation process comprises the following steps: weighing the medicinal materials according to the prescription proportion, soaking in 8 times of water for 0.5h, decocting for 2 times, each time for 1h, mixing the two decoctions, mixing, concentrating to 80% of the original medicinal liquid, filtering while hot, concentrating the filtrate to extract with relative density of 1.20-1.30 at 70deg.C, adding Mel, and stirring to obtain soft extract.
The usage amount is as follows: 3 times daily, 2-4g once, and is continuously taken for four weeks.
In order to verify the beneficial effects of the invention, the inventor performs relevant clinical experiments and experimental researches, and the experimental process and results are as follows:
1 clinical trial
1.1 case Source
Cases were from women acne patients who were diagnosed at a first affiliated hospital of the Guizhou university of traditional Chinese medicine (also known as Guizhou Miao), from 2021, 04, to 2022, 01, and the serum control group was healthy women who were reading at Guizhou university of traditional Chinese medicine during the study period. The final test group recorded 35 patients, dropped, removed 5, completed 30, and the serum control group completed 10. The difference in age distribution between the two groups of subjects tested was not statistically significant (P > 0.05).
1.2 diagnostic criteria
1.2.1 Western diagnostic criteria
The diagnosis standard for AV in the clinical dermatology written by Western medicine diagnosis standard reference Zhao Bian is preferably applied to teenagers, and is mainly characterized by black and white comedones and inflammatory papulopustules. The severity score for acne was graded using a grade 12 Cunliffe scale.
1.2.2 Chinese medicine differentiation and typing Standard
The differentiation and typing standard is prepared by referring to clinical experience and combining literature progress: (1) spleen deficiency fluid retention and (or) qi-blood disharmony: pale complexion or sallow complexion, preference for calm and lazy movement, tender flesh, cold limbs, chest distress and anorexia, thin stool, thirst, anorexia, greasy complexion, and thin and white leucorrhea. The tongue body is fat and has teeth marks on the side, and the tongue surface is lubricated. A pale or dull tongue. Thick or greasy coating. The pulse is deep, thin, wiry or slippery; pale complexion, dizziness, palpitation, dreaminess, cold ends, dry skin, irregular menstruation (stage of derivation, less amount of menstruation, dysmenorrhea, amenorrhea). A pale or dull tongue. The pulse is deep, thin and weak. (2) Heat toxin accumulating in skin: acne with pimple red; or with painful nodules, or with multiple pustules, even cysts; can be accompanied with thirst, and the rash is obviously aggravated after eating pungent and thick flavor or after staying up night, the tip of the tongue is red, and the tongue coating is yellow. Meanwhile, the syndrome of item (1) and (2) can be identified as the principal syndrome.
1.3 inclusion criteria
(1) Meets the diagnosis standard of acne vulgaris of Western medicine, and the grade is the first 7 patients by a Cunliffe grading method;
(2) meets the diagnosis standard of the spleen deficiency and fluid retention, qi-blood disharmony and heat toxin accumulation skin syndrome of the traditional Chinese medicine;
(3) women aged 18-45 years;
(4) the clinical test is voluntarily added, the requirement of the test is complied with, and the patient can take the medicine according to the doctor's advice to finish the test;
(5) each subject needs to take a photograph and cooperate to fill in the traditional Chinese medicine syndrome scoring table before treatment and sign an informed consent.
1.4 exclusion criteria
(1) Women in gestational lactation;
(2) acne resulting from the application of chemicals or pharmaceuticals;
(3) patients with serious primary diseases and mental diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system;
(4) drugs for treating acne such as retinoic acid, spironolactone, tanshinone, and Chinese medicine are taken in the last month;
(5) other facial diseases affecting the observation of efficacy.
1.5 drop and reject criteria
(1) Failure to complete a course of treatment or failure to cooperate with a therapist;
(2) terminating the tester due to serious adverse drug reactions;
(3) patients who are not in compliance with the medical advice in the treatment process.
1.6 method
Subjects meeting the standard were divided into A, B two groups (group a is the test group and group B is the serum control group) group a were subjected to the following interventions on the basis of treatment, group B was only serum control, and no other interventions were performed:
(1) Group a (test group):
1) Decoction for oral administration for resolving food stagnation and treating acne (the primary name of the recipe is simply called "acne-clearing decoction")
The composition is as follows:
15g of dandelion, 15g of weeping forsythia, 12g of bighead atractylodes rhizome, 9g of angelica, 12g of poria cocos, 9g of ligusticum wallichii, 30g of white peony root, 15g of rhizoma alismatis, 10g of radix angelicae, 10g of almond and 10g of platycodon grandiflorum;
adding, subtracting and cutting: radix Scutellariae 15g is added for patients with rash and cheek diseases; for those with rash and chin and mandible as main ingredients, fructus Gardeniae 10g and cortex Phellodendri 9g are added; facial greasiness: adding 9g of Sanxian (Sanxian, namely malt, hawthorn and Jian qu); rhizoma Pinelliae 9g is added to treat thick and greasy fur.
(1) The usage amount is as follows: one dose is taken every day, 5 days a week, 300ml of the medicine is brewed with boiled water, 150ml of the medicine is taken every morning and evening, and the medicine is continuously taken for four weeks.
2) Basic treatment (all recommended conventional treatment regimens for clinical professional guidelines/expert consensus):
(1) improved reverse powder for external use of I'm department with optimized proportion through research
The composition is as follows: crushing (powder preparation) rhubarb and sulfur in a ratio of 2:1 by an SF-400 type high-speed crusher (type I)
The usage amount is as follows: after face cleaning before sleeping, taking out the powder of the powder inversion, placing the powder into a cup, heating boiled water (the ratio of the powder to the boiled water is 1:1.5), fully and uniformly mixing the powder into paste (the degree that the powder is smeared on the back of the hand and does not drip), cooling the powder, externally applying the powder to the skin damage area with the thickness of about 2-3mm, scraping the medicine after 25 minutes, and cleaning the face with clean water once per night.
(2) Powder pricking needle picking and treating device
If the patient has skin lesions such as acne and pustule, acne and inflammatory secretion can be removed by sterilizing the acne needle.
(2) Group B (serum control group)
The serum control group was intended to select 30 healthy women without acne and to draw blood to measure hormone levels during 2-4 days of menstrual period.
1.7 observations index
(1) Test group: patient age, course of disease, skin lesion severity; scoring the traditional Chinese medicine symptoms and skin damage; serum hormone levels: DHEA and DHEA-S, IGF-1.
(2) Serum control group: age, DHEA-S, IGF-1 hormone levels.
1.8 efficacy assessment criteria
The preparation is formulated by referring to the main code of "New Chinese medicine clinical research guidelines for treatment" in 2002, zhengyu.
(1) The calculation formula is as follows:
efficacy index (%) = [ (pre-treatment integral-post-treatment integral)/pre-treatment integral ] ×100%.
Total effective rate (%) = [ (recovery + onset + efficacy)/total case number ] ×100%.
(2) Criterion for skin damage therapeutic effect
(1) The skin rash completely subsides, and only pigmentation and scar remain.
(2) Has obvious effect that the rash is resolved by more than 70 percent or the severity is reduced by more than 2 degrees.
(3) The effective rate is that the rash is resolved by more than or equal to 70 percent and more than 30 percent, or the severity is reduced by more than 1 degree, and new skin lesions still appear.
(4) Ineffective, rash resolved <30%, or aggravated.
1.9 statistical methods
The statistical method of the research adopts SPSS25.0 statistical software to carry out statistical analysis, and the hormone level, skin damage score and traditional Chinese medicine syndrome score of the patients in the test group before and after treatment adopt paired t test or accord with rank sum test; t test or rank sum test of independent samples is adopted in comparison between groups; and (3) aiming at the research of curative effect influence factors, taking the obvious effect as a positive event, and adopting two classification logistic regression analysis.
2 results
2.1 statistics of treatment effectiveness
The total effective rate of the test group is 90%, the average curative effect index is 55.42%, and the obvious effective rate is 33.33%, as shown in figure 1.
2.2 analysis of hormone levels in the Pre-treatment two groups
TABLE 1 analysis of DHEA and DHEAS levels in the Pre-treatment and serum control groups of the test group
TABLE 2 analysis of IGF-1 levels in the test and serum control groups prior to treatment
According to tables 1, 2: the test group has statistical significance (P is less than 0.05) in comparison of the levels of DHEA and DHEA-S, IGF-1 in the blank control group, and the level of the three hormones in the test group is higher than that in the normal group.
2.3 analysis of scores of DHEA, IGF-1, DHEA-S and traditional Chinese medical Condition and skin lesions before and after treatment of the test group
Table 3 DHEA analysis before and after treatment of the test group
TABLE 4 analysis of IGF-1, DHEA-S and traditional Chinese medical Condition score and skin lesion score before and after treatment in the test group
According to tables 3 and 4, the comparison of the DHEA, DHEA-S, IGF-1 and the traditional Chinese medicine syndrome score and the skin damage score analysis level has statistical significance (P is less than 0.05), and each hormone level and skin damage score of the patient after treatment are reduced compared with those before treatment.
Discussion 3
The common acne is clinically common damage-tolerant disease, and the inventor discovers that female acne patients commonly have deficiency-excess mixed cold-heat mixed symptoms for more than ten years and the series of symptoms are coagulated to form spleen deficiency and fluid retention, qi-blood disharmony and heat toxin accumulation skin symptoms; the traditional Chinese medicine composition is characterized by being beautiful and diet-saving, and the symptoms of listlessness, weakness, abdominal pain, anorexia, loose stool, spleen yang, deficiency of spleen yang, weak food essence, and deficiency of qi and blood are all seen in the prior art, and the symptoms of pale complexion, dizziness, weakness, insomnia, dreaminess, small menstruation and the like are seen. Yang Xumo the face is acne when the head is fumigated by damp-heat. Syndrome differentiation refers to spleen deficiency with retention of fluid, qi and blood disharmony and heat toxin accumulation in the skin, so it is applied to the treatment of fluid retention and serum acne decoction (the name of this preliminary name is abbreviated as "acne-clearing decoction").
For the research on the occurrence of acne, the major mechanism of the hormone level is considered to influence the secretion of sebaceous glands and the keratinization process of the sebaceous glands, and a specific mechanism is reported to be that the mechanism of promoting lipid synthesis by androgen is mainly that after the androgen is combined with an intra-sebaceous AR receptor, the phosphorylation level of mTOR is increased, so that the occurrence of a rapamycin target C1 pathway (mTORC 1) of a mammal is promoted, and a sterol regulatory element binding protein-1 (SREBP-1) is activated, so that the synthesis and secretion of lipid are promoted. Androgens can also induce differentiation of sebaceous gland cells by modulating Wnt/β -catenin pathway, and the differentiated sebaceous gland cells can exhibit high level AR, thereby promoting accumulation of lipids. In addition to the effects of T and DHT on this disease, studies have shown that DHEA and DHEA-S are also involved in the pathogenesis of acne, as they are converted to T and DHT as androgen precursors. It follows that the levels of DHEA and DHEA-S have a definite effect on the levels of T and DHT in sebocytes, and that the use of DHEA-based drugs has been reported to have definite adverse effects leading to acne. Kling CM and the like have proposed that peripheral metabolism of DHEA is a major contributor to circulating hormone levels in women, and 40% -75% of testosterone levels in pre-menopausal women are converted from DHEA, from which it can be speculated that levels of DHEA and DHEA-S are significant for female acne, and studies have demonstrated this. Whereas recent Meta analysis of the effects of DHEA on human insulin growth factor-1 (IGF-I) by Xie Ming et al suggests that supplementation with DHEA increases serum IGF-I levels, particularly in female subjects. IGF-I is also an important factor in the development of acne inflammation. Studies show that the sleep deficiency can cause insulin resistance, so that insulin secretion is increased, the promotion effect of the insulin on androgens is enhanced, the insulin also has definite effect of promoting IGF-1 production, and IGF-1 has the effects of promoting skin keratinocyte proliferation and androgenesis; wherein the androgen-production-promoting mechanism inhibits T-to-E2 by inhibiting androgen receptor signaling, indirectly leading to increased DHT; in addition, it can stimulate sebaceous gland cell proliferation, promote sebum synthesis and inflammatory factor generation. The clinical application of the prescription finds that the therapeutic effect is particularly good for female patients, and the prescription has definite hormone-like effect on the hormone level of DHEA, IGF-1 and DHEA-S, so the influence observation of the prescription on the hormone level of DHEA, IGF-1 and DHEA-S is developed.
In the results, the present formula may have mechanisms for regulating and controlling the IGF-1, DHEA and DHEA-S hormone levels, so that sebum secretion, keratinization of a follicular duct and inhibition of inflammatory factor release are indirectly regulated and controlled to achieve the treatment purpose, and particularly, a way and a target point for regulating and controlling the therapeutic effect need to be further explored.
4 clinical cases
Case 1:
wang Mou female, 25 years old, facial repeated rash accompanied with pain for 5 years, severe half month, facial multiple red pimple, acne and nodule, small amount of cyst, pustule at part of papule top, obvious tenderness, obvious pus and pus suppository acne overflow after extrusion, see fig. 2;
etiology of patient: the face gradually appears to be multi-divergent in pimple and red with tenderness before 5 years, powder fat-filled substances are extruded by hands to overflow and partially take the form of rice grain-shaped semitransparent particles, the doctor can ask for help from multiple prescriptions, the doctor can temporarily improve the skin rash by external wiping of vitamin A acid cream, external application of adapalene gel, external wiping of fusidic acid and the like, but the skin rash is always present, repeatedly aggravated with a small quantity of pustules, and the curative effect of oral minocycline and doxycycline is still not obvious. The rash is gradually increased before half month, the rash is bright red, pustules appear at partial top, pus overflows by squeezing with hands, and the skin rash is obviously painful, cold hands and feet and bitter taste. Plain menstrual disorder, less menstruation, aversion to cold, loose stool, dizziness, palpitation, insomnia, pale tongue, enlarged tongue body, tooth trace on the side of the tongue, watery tongue with white and greasy coating, deep and wiry pulse, and floating and rapid pulse;
family history: the father had severe acne, leaving a pit or scar on his face.
Diagnosis:
diagnosis of traditional Chinese medicine: acne [ heat toxin accumulated in the skin, spleen deficiency and fluid retention ]. Western diagnosis: acne vulgaris.
Prescription:
the traditional Chinese medicine is taken orally: 18g of dandelion, 20g of weeping forsythia, 12g of bighead atractylodes rhizome, 9g of angelica, 18g of poria cocos, 9g of ligusticum wallichii, 30g of white peony root, 15g of rhizoma alismatis, 10g of radix angelicae, 10g of almond and 10g of platycodon grandiflorum;
the using method comprises the following steps: decocting with water for oral administration, one dose per day (taken in three times);
and (5) re-diagnosis: after 10 days of continuous administration, the rash is obviously improved, the pustules are resolved, and the pain is obviously relieved. Palpitation and insomnia disappear, hands and feet are warmer than before, and bitter taste disappears.
Review prescriptions: the traditional Chinese medicine is taken orally: 18g of dandelion, 20g of weeping forsythia, 12g of bighead atractylodes rhizome, 9g of angelica, 18g of poria cocos, 9g of ligusticum wallichii, 30g of white peony root, 15g of rhizoma alismatis, 10g of radix angelicae, 10g of almond and 10g of platycodon grandiflorum;
the using method comprises the following steps: orally administered, one dose per day (taken in three times);
and re-diagnosis is carried out after the medicine is continuously taken for 10 days: the papules, nodules, cysts and pustules all resolve, no pain is felt, only the face has acne marks, pigmentation, palpitation and insomnia disappear, hands and feet are warmer than before, and the bitter taste disappears, as shown in figure 3.
Case 2:
cheng Mou A20 year old female, recurrent facial inflammatory papules, pustules for 1+ years, sallow complexion, four reversals, anorexia, loose stool, greasy complexion, enlarged tongue with teeth marks on the sides, lubricated tongue with pale tongue, thick and greasy coating, deep and slippery pulse, perioral inflammatory papules, pustules, brown crusta crust, partial fusion, cheek acne marks and pigmentation;
etiology of patient: papules, pustules, severe mouth Zhou You, pain caused by contact, and the like on the face during the period of 1+ years, the external medicine is purchased for self-use, and the skin damage is resolved after use, but any recurrent attacks are not diagnosed by the system, and the skin damage is aggravated during the period of time or the period of time after the night;
diagnosis:
diagnosis of traditional Chinese medicine: acne [ heat toxin accumulated in the upper part, spleen deficiency and fluid retention syndrome ], western diagnosis, acne;
prescription: the traditional Chinese medicine is taken orally: 10g of dandelion, 20g of weeping forsythia, 10g of angelica, 20g of white peony root, 20g of poria cocos, 10g of bighead atractylodes rhizome, 10g of rhizoma alismatis, 12g of ligusticum wallichii, 10g of platycodon grandiflorum, 6g of radix angelicae, 10g of almond, 20g of gardenia, 12g of salted phellodendron, 18g of radix scutellariae, 10g of malt, 10 of Jian yeast, 10 of hawthorn and 10g of rhizoma pinellinae praeparata;
the using method comprises the following steps: orally administered, one dose per day (taken in three times);
after 10 days of continuous administration, the inflammatory papules on the face are regressed, the mouth Zhou Qiuzhen and the pustules are obviously improved, more acne marks, pigmentation and dysmenorrhea are relieved.
Review prescriptions: the traditional Chinese medicine is taken orally: 20g of dandelion, 20g of weeping forsythia, 10g of angelica, 30g of white peony root, 10g of poria cocos, 20g of rhizoma alismatis, 6g of ligusticum wallichii, 10g of bighead atractylodes rhizome, 20g of gardenia, 12g of salted phellodendron bark, 18g of radix scutellariae, 10g of starter propagation, 10g of malt, 10g of hawthorn, 10g of platycodon grandiflorum, 10g of almond and 6g of radix angelicae;
the using method comprises the following steps: orally administered, one dose per day (taken in three times);
after further administration for 10 days, the inflammatory papules on the face regress, the mouth Zhou Qiuzhen and the pustules regress, the face has acne marks and pigmentation, and the dysmenorrhea does not exist.
Case 3:
yang Mou the female, 23 years old, repeated facial inflammatory papules 1+ years, sallow complexion, cold limbs, greasy skin, anorexia, sleepiness, pale tongue with greasy coating, smooth tongue surface, slippery pulse, red papules on the face, acne marks, pigmentation;
etiology of patient: there was no obvious cause of red pimple on the face before 1+ years, with pus spots, pain due to touch, the self-purchasing of fusidic acid cream was external, the rash was improved during use, the improvement of rash was not obvious after long-term use, and after that, each time was aggravated by staying up at night, having a large pressure or menstrual period, see fig. 4;
diagnosis: diagnosis of traditional Chinese medicine: acne [ pattern of heat-toxin accumulation and spleen-deficiency retention ]. Western diagnosis: acne.
Prescription: the traditional Chinese medicine is taken orally: 20g of dandelion, 15g of weeping forsythia, 10g of angelica, 10g of white peony root, 10g of poria cocos, 10g of bighead atractylodes rhizome, 10g of rhizoma alismatis, 10g of ligusticum wallichii, 18g of baical skullcap root, 12g of salted phellodendron bark, 10g of hawthorn, 10g of starter propagation, 10g of malt, 12g of platycodon root, 10g of almond, 10g of angelica dahurica, 9g of gardenia and 9g of rhizoma pinellinae praeparata;
the using method comprises the following steps: orally administered, one dose per day (taken in three times);
after taking the medicine continuously for 10 days, the patient is re-diagnosed, the inflammatory papule of the face is obviously improved, the facial powder is red papule, the diet is better, the complexion is light yellow, the four adverse effects are avoided, the sleep is still good, the T-shaped area of the skin is greasy, the patient can get the tongue fat, the patient has tooth marks on the side, the tongue surface is smooth, the tongue is light, the tongue coating is slightly greasy, and the pulse is slippery.
Review prescriptions: the traditional Chinese medicine is taken orally: 20g of dandelion, 12g of weeping forsythia, 10g of angelica, 10g of white peony root, 10g of poria cocos, 10g of bighead atractylodes rhizome, 10g of rhizoma alismatis, 12g of salted phellodendron bark, 10g of malt, 10g of ligusticum wallichii, 18g of baical skullcap root slices, 10g of hawthorn, 10g of Jianqu, 12g of platycodon grandiflorum, 10g of radix angelicae, 10g of almond and 10g of gardenia;
the using method comprises the following steps: orally administered, one dose per day (taken in three times);
after another 10 days of continuous administration, the inflammatory papules on the face subsided, and the face had a small number of acne marks and a pale pigmentation, see fig. 5.
Claims (9)
1. A Chinese medicinal preparation for treating female acne is characterized in that: the medicinal active ingredients are calculated according to the weight components: is prepared from 130-170 parts of dandelion, 130-170 parts of weeping forsythia, 100-140 parts of bighead atractylodes rhizome, 70-110 parts of angelica, 100-140 parts of poria cocos, 70-110 parts of ligusticum wallichii, 200-400 parts of white peony root, 130-170 parts of rhizoma alismatis, 80-120 parts of radix angelicae, 80-120 parts of almond and 80-120 parts of balloonflower root.
2. The traditional Chinese medicine preparation for treating female acne according to claim 1, wherein: the medicinal active ingredients are calculated according to the weight components: is prepared from 150 parts of dandelion, 150 parts of weeping forsythia, 120 parts of bighead atractylodes rhizome, 90 parts of Chinese angelica, 120 parts of poria cocos, 90 parts of ligusticum wallichii, 300 parts of white peony root, 150 parts of rhizoma alismatis, 100 parts of radix angelicae, 100 parts of almond and 100 parts of orange stems.
3. The traditional Chinese medicine preparation for treating female acne according to any one of claims 1 or 2, characterized in that: the acne patient has rash with cheek, and 100-220 parts of radix Scutellariae is added in the prescription.
4. The traditional Chinese medicine preparation for treating female acne according to any one of claims 1 or 2, characterized in that: the acne patient has rash with chin and lower jaw as main part, and fructus Gardeniae 50-200 parts and cortex Phellodendri 40-160 parts are added.
5. The traditional Chinese medicine preparation for treating female acne according to any one of claims 1 or 2, characterized in that: the acne patient has thick greasy coating, and 40-160 parts of rhizoma pinellinae praeparata is added in the prescription.
6. The traditional Chinese medicine preparation for treating female acne according to any one of claims 1 or 2, characterized in that: the acne patient has greasy face, and 40-160 parts of malt, 40-160 parts of hawthorn and 40-160 parts of Jian qu are added in the prescription.
7. A method for preparing a traditional Chinese medicine preparation for treating female acne according to any one of claims 1-6, characterized in that: all the medicinal materials are weighed according to the proportion, processed according to the conventional preparation method, combined with pharmaceutically acceptable auxiliary materials in the medicament, and prepared into corresponding oral preparations.
8. The method for preparing the traditional Chinese medicine compound for treating female acne according to claim 7, which is characterized in that: the oral preparation comprises powder, capsules, tablets, pills, granules or soft extract.
9. The method for preparing the traditional Chinese medicine compound for treating female acne according to claim 8, which is characterized in that: the preparation method of the powder comprises the following steps: weighing the raw materials according to a certain proportion, pulverizing into fine powder, and mixing uniformly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211584193.0A CN115779025B (en) | 2022-12-09 | 2022-12-09 | Traditional Chinese medicine preparation for treating female acne and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211584193.0A CN115779025B (en) | 2022-12-09 | 2022-12-09 | Traditional Chinese medicine preparation for treating female acne and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115779025A CN115779025A (en) | 2023-03-14 |
CN115779025B true CN115779025B (en) | 2024-02-23 |
Family
ID=85418420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211584193.0A Active CN115779025B (en) | 2022-12-09 | 2022-12-09 | Traditional Chinese medicine preparation for treating female acne and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115779025B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579608A (en) * | 2011-01-17 | 2012-07-18 | 高国华 | Freckle removing liquid |
CN104547732A (en) * | 2014-11-27 | 2015-04-29 | 林康艺 | Traditional Chinese medicine composition for treating acne |
CN109498714A (en) * | 2018-12-19 | 2019-03-22 | 中山大学附属口腔医院 | Danggui shaoyao san |
CN110448653A (en) * | 2018-05-07 | 2019-11-15 | 天津泰源中草药技术开发有限公司 | A kind of Chinese medicine preparation and preparation method thereof for treating skin of face |
-
2022
- 2022-12-09 CN CN202211584193.0A patent/CN115779025B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579608A (en) * | 2011-01-17 | 2012-07-18 | 高国华 | Freckle removing liquid |
CN104547732A (en) * | 2014-11-27 | 2015-04-29 | 林康艺 | Traditional Chinese medicine composition for treating acne |
CN110448653A (en) * | 2018-05-07 | 2019-11-15 | 天津泰源中草药技术开发有限公司 | A kind of Chinese medicine preparation and preparation method thereof for treating skin of face |
CN109498714A (en) * | 2018-12-19 | 2019-03-22 | 中山大学附属口腔医院 | Danggui shaoyao san |
Non-Patent Citations (7)
Title |
---|
中西医结合治疗女性面部痤疮60例;曹青霞;;中医研究;-(12);全文 * |
中西医结合治疗痤疮;欧其平, 林维山;中华皮肤科杂志;-(09);全文 * |
中西医结合治疗重度烧伤中期患者50例;李春耕;丛坤;;山东中医杂志;-(07);全文 * |
当归芍药散新用3则;祁宝菊;;山西中医;-(01);全文 * |
当归芍药散治疗粉刺1例;邱锋;许鸿佳;;光明中医;-(12);全文 * |
郁东海.治未病学.上海科学技术出版社,2018,310-314. * |
陈信生.当代皮肤科临床家丛书 第3辑 范瑞强.中国医药科技出版社,2017,33-34. * |
Also Published As
Publication number | Publication date |
---|---|
CN115779025A (en) | 2023-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102755596B (en) | Traditional Chinese medicine for treating phlegm-dampness hyperplasia of mammary glands and preparation method thereof | |
CN104383296B (en) | Traditional Chinese medicine composition for treating xerophthalmia and preparation method thereof | |
CN104491755A (en) | Traditional Chinese medicine composition for treating abdominal distension and preparation method of traditional Chinese medicine composition | |
CN104940740A (en) | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method thereof | |
CN103055239B (en) | Traditional Chinese medicine for beautifying face and removing freckles and preparation method thereof | |
CN103736036A (en) | Drug for treating nonalcoholic fatty liver disease and preparation method thereof | |
CN104225078A (en) | Traditional Chinese medicine composition and preparation method thereof for treatment of chloasma | |
CN108186863A (en) | A kind of Chinese medicine for treating psoriasis | |
CN102552748B (en) | Traditional Chinese medicine capable of maintaining beauty and keeping young | |
CN115779025B (en) | Traditional Chinese medicine preparation for treating female acne and preparation method thereof | |
CN104906430A (en) | Traditional Chinese medicine preparation for treating xerophthalmia and preparation method thereof | |
CN104906507A (en) | Traditional Chinese medicine combination for lowering blood pressure and toning physical fitness | |
CN104815232A (en) | Traditional Chinese medicine preparation for treating primary pulmonary hypertension and preparation method thereof | |
CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
CN104524479B (en) | A kind of Chinese medicine composition for treating premenstrual syndrome and preparation method thereof | |
CN103989996A (en) | Traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
CN112023010A (en) | Traditional Chinese medicine composition for slimming, preparation method thereof, oral medicine and application | |
CN105535839A (en) | Traditional Chinese medicine tablets for treating colon cancer and preparation method thereof | |
CN104840773A (en) | Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same | |
CN109464565A (en) | A kind of Chinese medicine composition and its preparation for treating chest impediment and cardialgia | |
CN103690816B (en) | Eliminate Chinese medicine composition of insufficiency of the spleen phlegm-damp Cystic hyperplasia of breast and preparation method thereof | |
CN102805825A (en) | Drug for curing cutaneous pruritus and preparation method thereof | |
CN111643557B (en) | Pharmaceutical composition for preventing and treating sequela of deep venous thrombosis of lower limbs and preparation method and application thereof | |
CN108704040B (en) | Traditional Chinese medicine composition and application thereof | |
CN106039030A (en) | Granules capable of clearing bowels, expelling toxins and beautifying face |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |